Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine
Michael D. Lesem(Claghorn Lesem Research Clinic), James V. Cassella(Trevi Therapeutics (United States)), Daniel A. Spyker(Alexza Pharmaceuticals (United States)), Tram Tran-Johnson, Robert Fishman, Michael H. Allen, David Feifel, John H. Kehne, Robert Riesenberg
Cited by 153
Related Papers
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
|New England Journal of Medicine|2007|925
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
|The Lancet|2018|780
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
|The Lancet|2017|474
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
|European Respiratory Journal|2015|462
The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup
|Western Journal of Emergency Medicine|2012|386